US FDA issues guidance on development of COVID-19 vaccines, including that a vaccine would need to prevent or lessen the severity of COVID-19 in at least 50% of people who have been vaccinated. The guidance also specifically encourages enrollment of racial and ethnic minorities, the elderly, and people with underlying medical conditions. Sources 1,2
